Navigation Links
PRX in Medical News

Par Pharmaceutical Reports EPS of $0.71 for Second Quarter 2009

... WOODCLIFF LAKE, N.J., Aug. 4 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: prx ) today reported results for the second quarter ended June 27, 2009. For the second quarter ended June 27, 2009, Par reported total revenues o...

Par Pharmaceutical to Host Second Quarter 2009 Earnings Conference Call on August 4 at 9:00 am

... WOODCLIFF LAKE, N.J., July 15 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: prx ) announced today that it will host a conference call and live webcast on Tuesday, August 4, 2009 at 9:00 am EDT to review results for the second quar...

Thomas P. Rice Elected to Board of Directors of Par Pharmaceutical Companies, Inc.

... WOODCLIFF LAKE, N.J., June 12 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: prx ) today announced that Thomas P. Rice has been elected to the company's board of directors. Mr. Rice was also appointed to the Audit Committee and th...

MonoSol Rx Announces FDA Acceptance of NDA for Ondansetron Orally Dissolving Film Strip

...the tongue. MonoSol Rx and its partner Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE: prx ), are seeking FDA approval of ondansetron ODFS for the prevention of nausea and vomiting associated with highly- and moderately-emetogenic chemothera...

Par Pharmaceutical Begins Shipment of Generic Miacalcin(R)

... WOODCLIFF LAKE, N.J., June 9 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: prx ) today announced that it began shipping calcitonin-salmon nasal spray to the trade. Calcitonin-salmon nasal spray is a generic version of Novartis' ...

Par Pharmaceutical Reports Adjusted EPS of $0.49 for First Quarter 2009

...ins and Higher Sales of Select Generic Products WOODCLIFF LAKE, N.J., May 6 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: prx ) today reported results for the first quarter ended March 28, 2009. Par reported total revenues of $204.0 million and net income of $16.1 milli...

Par Pharmaceutical Enters Into Agreement With Reliant Pharmaceuticals to Settle Patent Litigation Over Rythmol(R) SR

... WOODCLIFF LAKE, N.J., April 21 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: prx ) ("Par") today announced it has entered into a settlement agreement with Reliant Pharmaceuticals, Inc. ("Reliant") that resolves patent litigation re...

Strativa Pharmaceuticals Provides Product Pipeline Update

...-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: prx ), today provides an update on two of its pipeline products. Ondansetron Orally Dissolving Film Strip On April 7, 2009, Strativa submitt...

MonoSol Rx and Strativa Pharmaceuticals Submit New Drug Application for Ondansetron Orally Dissolving Film Strip

...ving thin film pharmaceutical products, and Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE: prx ), today announced the submission on April 7, 2009 of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for the orally disso...

Strativa Pharmaceuticals Acquires Worldwide Rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray From QOL Medical

...-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: prx ), today announced it has acquired the worldwide rights to Nascobal(R) (Cyanocobalamin, USP) Nasal Spray from QOL Medical LLC. Nascobal Nasal Spray ...
PRX in Medical Technology

Strativa Pharmaceuticals Provides Product Pipeline Update

...-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: prx ), today provides an update on two of its pipeline products. Ondansetron Orally Dissolving Film Strip On April 7, 2009, Strativa submitt...

Strativa Pharmaceuticals Announces Preliminary Results from ONCONASE(R) Phase IIIb Clinical Trial

...LAKE, N.J., May 29 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE: prx ) today announced that its development partner, Alfacell Corporation (Nasdaq: ACEL ) reported that the preliminary statistical analysis of data from ...

Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis

...KE, N.J., April 21 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE: prx ) today announced that its development partner, BioAlliance Pharma reported preliminary, top-line results for a Phase III study of Loramyc(R) (miconaz...

Chinese SFDA Grants Immtech Fast Track Status

...e and effective drugs to market." In June 2007, Immtech entered into an exclusive licensing agreement with Par Pharmaceutical Companies, Inc. (NYSE: prx ) under which Par will receive commercialization rights in the U.S. to pafuramidine for the treatment of PCP in AIDS patients. About Immtech Pharmace...

Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)

... WOODCLIFF LAKE, N.J., Aug. 3 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: prx ) today announced it had begun shipping metoprolol succinate extended release 50 mg tablets. As previously announced, in November 2006 Par entered int...

Protox Announces Publication in Journal of the National Cancer Institute Supporting PRX302 as Treatment for Prostatic Diseases

...Drugs VANCOUVER, March 20 /CNW/ - Protox(TM) Therapeutics Inc. (TSX-V:PRX) today announced that two peer-reviewed publications will feature Protox's prx 302. The Journal of the National Cancer Institute ("JNCI") has published the work conducted by Dr. Sam Denmeade and his team at Johns Hopkins Universi...
PRX in Biological News

Research explores role of hydrogen peroxide in cell health

...rx) helps control levels of the agent. The role of prx is important because if the levels of hydrogen per...at leads to cancer, diabetes and other disease. prx actually has a dual role in the process. Its usual... to water. But if levels get dangerously high and prx needs help it becomes inactive in its converting ...
PRX in Biological Technology

Strativa's Development Partner, BioAlliance Pharma, Submits Loramyc(R) NDA

...-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: prx ), today announced that its development partner, BioAlliance Pharma, has submitted a New Drug Application (NDA) to the Food and Drug Administration (F...

Strativa's New Drug Application for Ondansetron Orally Dissolving Film Strip Accepted by FDA

...-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of a wholly owned subsidiary of Par Pharmaceutical Companies, Inc. (NYSE: prx ), today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for ondansetron orally dissolving film...

Par Pharmaceutical to Present at the 27th Annual J.P. Morgan Healthcare Conference

... WOODCLIFF LAKE, N.J., Jan. 7 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: prx ) will be presenting at the 27th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, at 3:00 pm PST at the Westin St. Francis Hotel. ...

Strativa Pharmaceuticals Announces Successful Completion of Bioequivalence Studies for Ondansetron Thin Film

...AKE, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE: prx ) today announced that its development partner, MonoSol Rx, reported the successful completion of all pivotal bioequivalence studies for a thin film f...

Par Pharmaceutical Halts Shipment of Budesonide Inhalation Suspension

... WOODCLIFF LAKE, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: prx ) today announced that the U.S. District Court for the District of New Jersey last night granted AstraZeneca Pharmaceuticals' motion for a temporary r...

Par Pharmaceutical Reports Second Quarter 2008 Results

...hes Should Contribute Significantly in Second Half WOODCLIFF LAKE, N.J., Aug. 7 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: prx ) today announced results for the second quarter ended June 28, 2008. Second Quarter and Six Month Results For the second quarter ended June 28, 2...

Par Pharmaceutical to Host Second Quarter 2008 Results Conference Call on August 8 at 9:00 am

... WOODCLIFF LAKE, N.J., July 29 /PRNewswire-FirstCall/ - Par Pharmaceutical Companies, Inc. (NYSE: prx ) announced today that it will host a conference call and live webcast on Friday, August 8, 2008 at 9:00 am ET to review results for the second quarte...

Par Pharmaceutical to Launch meclizine HCL Tablets

... WOODCLIFF LAKE, N.J., July 9 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: prx ) today announced that it will commence shipment of 12.5mg and 25mg meclizine HCl tablets immediately. At this time, Par believes it is the exclusive ...

Par Pharmaceutical Receives Final Approval to Market Generic Marinol(R) CIII (Dronabinol) Capsules

...Shipping Dronabinol Soft Gel Capsules Immediately WOODCLIFF LAKE, N.J., June 30 /PRNewswire-FirstCall/ -- Par Pharmaceutical Companies, Inc. (NYSE: prx ) today announced that it has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for dronabin...

Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

...SDAQ: NUVO ) PAR PHARMACEUTICAL COS INC. (NYSE: prx ) SANGAMO BIOSCIENCES INC. (NASDAQ: SGMO ) SCIE...ASDAQ: HOLX ) PAR PHARMACEUTICAL COS INC (NYSE: prx ) SUCAMPO PHARMACEUTICALS INC (NASDAQ: SCMP ) V...ASDAQ: MYGN ) PAR PHARMACEUTICAL COS INC (NYSE: prx ) PHARMASSET INC (NASDAQ: VRUS ) SHIONOGI & CO ...
PRX in Biological Products

Rabbit Anti-Peroxiredoxin 1 Polyclonal Antibody, Unconjugated from GeneTex

Description:...throughout all the kingdoms. Among them, mammalian prx consists of 6 different members grouped into typic...Prx, and 1-Cys Prx. Except Prx6 belonging to 1-Cys prx subgroup, the other five 2-Cys prx isotypes have the thioredoxin-dependent peroxidase...
Company:GeneTex
Other Tags
(Date:3/27/2015)... Ticket Down is a reputable source of authentic ... Nebraska on Friday, May 8th and Saturday, May 9th. ... added in Omaha as Garth has done in other markets ... World Tour is continuing its run throughout the United States ... Trisha Yearwood will bring their act to Omaha, NE at ...
(Date:3/27/2015)... CA (PRWEB) March 27, 2015 Endure ... Yoga for functional fitness athletes. This new program matches ... specific protocol for post-workout cool down. This program utilizes ... breath control and mental focus. , Karen Lefurgy, ... started practicing yoga long before I started Crossfit® training, ...
(Date:3/27/2015)... SMI (Silicon Microstructures, Inc.), a global MEMS ... SM1120 MEMS based ultra-miniature pressure sensor designed especially for ... only 220um x 75um provides ample space for 1-French ... With industry leading in vivo drift performance of ... operating pressure range from 0 to 1,100 mmHg absolute. ...
(Date:3/27/2015)... March 27, 2015 Operatic contenders and ... greatness on April 17th. The universally acclaimed baritone Sherrill ... 9th annual Opera Idol at The Merion in Evanston. ... which has drawn aspiring opera singers from around the ... some of the finest young talent in the country,” ...
(Date:3/27/2015)... Dallas, Texas (PRWEB) March 27, 2015 ... Global Glutathione Industry is a professional and in-depth ... glutathione market with a focus on ... basic overview of the industry including definitions, classifications, ... analysis is provided for both the international and ...
Breaking Medicine News(10 mins):Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 2Health News:Cheap Garth Brooks Tickets for CenturyLink Center in Omaha: Ticket Down Slashes Garth Brooks Concert Tickets in Omaha, NE at the CenturyLink Center 3Health News:Endure Yoga Introduces WOD Recovery Yoga 2Health News:SMI Launches Catheter Mountable Pressure Sensor 2Health News:Opera Idol Competition At The Merion In Evanston 2Health News:Glutathione Industry International and China Market Analysis Report 2015-2020 2Health News:Glutathione Industry International and China Market Analysis Report 2015-2020 3
(Date:3/12/2015)... 12, 2015 Beta Systems ... and access management (IAM) solution for a fixed ... Beta System,s new IAM package, customers benefit from ... from multiple IAM implementations across different industries. The ... well as any necessary services and consulting. It ...
(Date:3/10/2015)... Transforming How We Look at ... in Human Space Flight" by Michael A. ... Ph.D. was recently featured by Springer Science Media, highlighting the ... Specifically, "Personalized Medicine in Human Space Flight" was ... 2013 and 2014 from Springer in the journal ...
(Date:3/3/2015)... FOREST, Calif. , March 3, 2015 ... the leading provider of advanced cryogenic logistics ... markets including immunotherapies, stem cells, cell lines, ... and reproductive medicine, today announced the expansion ... Cancer Research Centers, ("Fred Hutch") Clinical ...
Breaking Biology News(10 mins):Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 2Cryoport, Inc. Expands Support of Fred Hutchinson Cancer Research Center's Clinical Research Division 3
Other Contents